Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byBiogen Idec
Price$750M
Date2/2014

General Information

Offices

Cambridge, USA
One Canal Park
Suite 1120
Cambridge, MA, 02141
USA

People

Founder and CEO
Vice President, Research
Board Member
Board of Directors
Chief Medical Officer
Executive Chairman
Chief Development Officer

Funding

Tags

Stromedix

Stromedix will focus initially on chronic indications but plans to leverage its expertise and expand its therapeutic pipeline into related settings such as acute organ failure and cancer.

Recent Milestones

Videos

Screenshots

Stromedix screenshot
Above: Homepage
Uploaded: 6/4/09

Sources

  1. Biogen Idec Commits Up to $487.5M to Acquire Stromedix (burrillreport.com) [edit]
  2. EDGAR [edit]
  3. Capital Funding Report [edit]
  4. Stromedix lands $2M, looks for $15.5M in new funding (masshightech.com) [edit]
  5. Stromedix lands $2M, looks for $15.5M in new funding (masshightech.com) [edit]
Edit This Page
Last Edited 4/13/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy